Imaging of brain tumours to get a boost in New Zealand - FET PET/CT
F18-FEMPA is a novel radiotracer owned by Piramal Imaging and produced under license by Cyclo
New Zealand brain researchers using PET/CT - FBB in a study of Parkinson’s disease
Clinicians at PAH evaluating F18-FBB myocardial uptake for detection of cardiac amyloidosis
Cyclotek Queensland completes the build phase of Building 39, Princess Alexandra Hospital.
Cyclotek licences 18F-DCFPyL for Australia and New Zealand